Tag results:
neutrophils
Immune Regulation News
SEC61G Overexpression and DNA Amplification Correlates with Prognosis and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma
[Cancer Medicine] SEC61G expression was analyzed using publicly available datasets. The association between SEC61G and disease prognosis was evaluated.
Extracellular Matrix News
Signaling through TLR5 Mitigates Lethal Radiation Damage by Neutrophil-Dependent Release of MMP-9
[Cell Death Discovery] Scientists demonstrated that in contrast to radioprotection, neutrophils were essential for the radiomitigative activity of entolimod in a mouse model of lethal acute radiation syndrome. Recombinant MMP-9 by itself had radiomitigative activity and, in the absence of neutrophils, accelerated the recovery of the hematopoietic system.
Umbilical & Placental Cell News
Total Body Irradiation-Containing Conditioning Regimens without Antithymocyte Globulin in Adults with Aplastic Anemia Undergoing Umbilical Cord Blood Transplantation
[Annals of Hematology] The authors compared transplantation outcomes between a fludarabine (Flu)- and melphalan-based regimen and a Flu- and cyclophosphamide-based regimen
Intestinal Cell News
The ATP-Hydrolyzing Ectoenzyme E-NTPD8 Attenuates Colitis through Modulation of P2X4 Receptor–Dependent Metabolism in Myeloid Cells
[Proceedings of the National Academy of Sciences of the United States of America] The molecular mechanism by which microbiota-derived ATP in the colon is regulated remains poorly understood. Researchers showed that E-NTPD8 was highly expressed in large-intestinal epithelial cells and hydrolyzed microbiota-derived luminal ATP.
Immune Regulation News
Glucose Inhibits Hemostasis and Accelerates Diet-Induced Hyperlipidaemia in Zebrafish Larvae
[Scientific Reports] The authors investigated the utility of zebrafish larvae to model the effect of exogenous glucose on neutrophil and macrophage recruitment to a tail wound, wound-induced hemostasis, and chicken egg yolk feed challenge-induced hyperlipidaemia by supplementing larvae with exogenous glucose by immersion or injection.
Hematopoiesis News
Delayed Administration of Ixazomib Modifies the Immune Response and Prevents Chronic Graft-versus-Host Disease
[Bone Marrow Transplantation] Investigators aimed to modify the immune response in the long term after allogeneic bone marrow transplantation by using the proteasome inhibitor ixazomib at the late stages of the post-transplant period.